Search

file (14) (1)

Investor Overview

Investor Overview

HOMEInvestor Overview

Read More

2026.Apr.09

News

OBI Presents Obrion™ ADC Technologies at AntibodyChina 2026 in Shanghai
Highlighting Scalable Manufacturing and Bispecific Dual-Payload Design

2026.Apr.02

News

OBI Participated in BIO-Europe Spring®, Advancing International Business Development
Engaged with Multiple Global Pharma Companies for Licensing Discussions

2026.Apr.01

News

OBI Announces Final Arbitral Award in Contract Dispute with Biosion
Clinical Development and Global Strategy Continue as Planned with Related Programs Unaffected

Read More

2026.Apr.01

Announcement

Announcement of the Final Award of the Rapid Arbitration Initiated by OBI in Delaware, USA Against Biosion

2026.Mar.24

Announcement

Announcement on behalf of Amaran of not Distributing Dividends of 2025

2026.Mar.24

Announcement

Announcement on behalf of Amaran that the BOD resolved to convene the 2026 Annual General Shareholders' Meeting

2024 Annual Report

Learn how we created value in 2024 and worked to pursue our purpose of enabling a healthier world.

Download PDF
Read More

Featured
Presentation

2025 Investors' Meeting - Driving Value Transformation Through ADC Innovation

Download PDF

Read More

2025 First Extraordinary General Shareholders’ Meeting

  • 2025.Oct.20 at 09:00 AM
  • Taipei Bioinnovation Park 1F Conference Room
Youtube

Governance

Read More

Corporate
Overview​

Board of
Directors​

Special ​
Committee​

Integrity​

Internal
Audit​

Governance
Document​

Investor Relations

Contact